Detalles de la búsqueda
1.
The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease.
Alzheimers Dement
; 20(2): 1298-1308, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985413
2.
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
Brain
; 145(7): 2507-2517, 2022 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088840
3.
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment.
J Nanobiotechnology
; 21(1): 54, 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788617
4.
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674881
5.
Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.
Int J Mol Sci
; 24(2)2023 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674414
6.
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
Mol Psychiatry
; 26(10): 5797-5811, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34112972
7.
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.
Int J Mol Sci
; 23(13)2022 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805894
8.
Identification of undiagnosed dementia cases using a web-based pre-screening tool: The MOPEAD project.
Alzheimers Dement
; 17(8): 1307-1316, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860599
9.
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
Acta Neuropathol
; 139(6): 1025-1044, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166339
10.
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid ß burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Alzheimers Dement
; 14(5): 634-643, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29156223
11.
PLD3 in non-familial Alzheimer's disease.
Nature
; 520(7545): E3-5, 2015 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25832411
12.
Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment.
Alzheimers Dement
; 12(8): 872-81, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26921674
13.
Design of a comprehensive Alzheimer's disease clinic and research center in Spain to meet critical patient and family needs.
Alzheimers Dement
; 10(3): 409-15, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035148
14.
Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum.
Alzheimers Res Ther
; 16(1): 26, 2024 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308366
15.
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort.
Alzheimers Res Ther
; 16(1): 42, 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378643
16.
Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort.
Alzheimers Res Ther
; 16(1): 38, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365752
17.
Clinical performance of an antibody-free assay for plasma Aß42/Aß40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
Alzheimers Res Ther
; 15(1): 2, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604729
18.
Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment.
Front Neurosci
; 17: 1221401, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746151
19.
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort.
Front Neurosci
; 17: 1076177, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908784
20.
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.
Sci Rep
; 13(1): 5406, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012306